Compounds > gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate
Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Cancer of the Thyroid

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Cancer of the Thyroid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dralle, H; Freesmeyer, M; Winkens, T1

Other Studies

1 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Cancer of the Thyroid

ArticleYear
Diagnosis of small medullary thyroid carcinoma via PET/ultrasound (US) fusion.
    Japanese journal of clinical oncology, 2014, Volume: 44, Issue:3

    Topics: Aged; Carcinoma, Neuroendocrine; Contrast Media; Female; Heterocyclic Compounds; Humans; Incidental Findings; Iodine Radioisotopes; Organometallic Compounds; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography

2014